New collaboration will enable scalable, cost-effective manufacturing processes CARLSBAD, Calif. — Thermo Fisher Scientific, the world leader in serving science, today announced a collaboration with Scinogy, specialists in closed, automated manufacturing systems for cell therapies, to develop and commercialize fit-for-purpose instrumentation and reagent systems aimed at improving productivity and scalability of cell and gene therapy manufacturing. […]

SAN JOSE, Calif. — Complete Genomics Inc., a US subsidiary of MGI, has filed a patent infringement lawsuit against Illumina in US District Court for the District of Delaware. The lawsuit alleges that a number of genetic sequencers and related reagents from Illumina, including the NovaSeq 6000, NextSeq series, and MiniSeq, are infringing Complete Genomics’ U.S. Patent No. 9,222,132 […]

At Benchling, we’ve been fortunate to support scientists doing some of the world’s most groundbreaking research—from designing CRISPR experiments and engineering CAR T cells to producing novel biomaterials. Over the years, more than 170,000 scientists have depended on Benchling to design DNA, collaborate on experiments, and manage complex research workflows. Many of these scientists are […]

USPTO issues fifth U.S. CRISPR-Cas9-related patent to University of California, for new methods of modulating DNA transcription BERKELEY, Calif. — The U.S. Patent and Trademark Office has issued a new patent to University of California (UC), University of Vienna, and Dr. Emmanuelle Charpentier covering methods of modulating DNA transcription using the CRISPR-Cas9 system. U.S. Patent No. 10,301,651 covers techniques that enable […]

VANCOUVER – Two million Canadian children are classified as having a rare disease. As these children and their families navigate these complex, life-threatening, or chronically debilitating conditions, their stories are often similar — they spend years experiencing a diagnostic odyssey that includes many hospital and clinic visits, tests and several misdiagnoses before a firm diagnosis is […]

USPTO issues fifth U.S. CRISPR-Cas9-related patent to University of California, for new methods of modulating DNA transcription BERKELEY, Calif. — The U.S. Patent and Trademark Office has issued a new patent to University of California (UC), University of Vienna, and Dr. Emmanuelle Charpentier covering methods of modulating DNA transcription using the CRISPR-Cas9 system. U.S. Patent No. 10,301,651 covers techniques that enable […]

Loop Genomics deploys new sequencing technology and protocols to provide unparalleled insight into microbiome research San Jose, CA – Loop Genomics, the single molecule long-read sequencing company with a hardware free solution, has expanded its kit and services capabilities to provide researchers with new ultra-high resolution Microbiome sequencing solutions using long-reads on Illumina sequencers. The […]

NEWARK, Calif., & QUEBEC CITY–ATUM, a Newark, California-based leader in the development of protein expression technologies, announced today the exclusive licensing of gene-coding algorithm GeneGPS® to optimize protein expression in Nicotiana benthamiana to Medicago, a global leader in the development and production of plant-derived vaccines and therapeutic proteins. The gene design technology was developed using ATUM’s patented gene […]

SAN FRANCISCO–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced it appointed Nelson C. Chan, former CEO of Magellan, as a Class I director to its board of directors. Mr. Chan brings more than 35 years of experience as both […]

Student-led experiment edits yeast genes to study DNA repair in space  Cambridge, MA – For the first time, astronauts have used CRISPR/Cas9 technology to edit DNA in space. The gene editing technique was deployed on the International Space Station (ISS) to induce targeted breaks in the yeast genome. Molecular changes left behind as yeast repair these breaks […]